Health System

ASHP continues to make solving the drug shortages problem a top priority.

It can be helpful to know the guidelines concerning anticoagulation and common outpatient procedures.

What would happen if some future corporation decides it's more productive to revert back to the days of the typewriter?

Implementation of the "biosimilars" law is going well, but the exclusivity period seems to be a problem.

Walgreens' new "Well Experience" stores feature the pharmacist being out on the floor, and the concept is working very well.

Occasionally mergers receive the attention of Congress, especially when consumer welfare and jobs are at stake. A prime example: The proposed merger of Express Scripts and Medco Health Solutions.

Feet were the No. 1 body part to experience pain, even more so than the teeth or skin, survey responders admitted. Help is on the way.

The message: Experience finally matters.

The next decade will see a significant increase in the rate of practical applications for pharmacogenomics becoming available, and pharmacists will play a critical role in helping them benefit the patient.

Requiring prior authorization may have a broader impact than expected.

Readers speak out about the title of "Dr." and pharmacies in Canada.

Experts caution that many unregulated over-the-counter fish oil products have little benefit, with some having no benefit at all.

A survey of new Rx, new generic, and new OTC products

The Ohio commercial activity tax law ("CAT") is an annual tax on the privilege of doing business in Ohio.

Prescriptions could take on a new look if the Office of the Inspector General gets its way.

The EPA is looking for mismanagement of hazardous pharmaceutical waste generated by hospitals and other healthcare facilities. The odds are good that your hospital is in violation.

Technology is the pharmacist's toolbox. Here are some apps to help you extend your care.

The outcry from physicians, pharmacists, and patients over disruptions in supplies of vital medications continues to draw attention on Capitol Hill and throughout the healthcare system.

Two Long Island University pharmacists are reversing the usual course of MTM. Instead of waiting for patients and prescriptions to come to the pharmacy, they are taking MTM to patients.

The CDC found that just 4 classes of prescription drugs are responsible for more than two-thirds of drug-related hospitalizations in older patients.

FDA approved ruxolitinib (Jakafi), a twice-daily tablet, indicated for the treatment of myelofibrosis, a rare bone marrow disease that affects less than 200,000 people in the United States.

One area that has remained cloudy for prescribers and patients is: "How much does this medication actually cost?"

FDA has approved alendronate sodium (Binosto, EffRx Pharmaceuticals) effervescent tablets, the first effervescent osteoporosis treatment in a buffered solution.

Teva/IVAX Pharmaceuticals gained FDA approval for the first generic version of Lexapro (Forest) to treat both depression and generalized anxiety disorder in adults. The company will have 180 days to exclusively sell the product.

The FDA's Center for Drug Evaluation and Research (CDER) released a new draft guidance on how it develops and classifies drug-safety issues.